Cellosaurus logo
expasy logo
Due to maintenance work, this service will be unavailable Tuesday 16 between 06:00 and 06:30 - CEST. Apologies for the inconvenience.

Cellosaurus OVSAYO (CVCL_3115)

[Text version]
Cell line name OVSAYO
Accession CVCL_3115
Resource Identification Initiative To cite this cell line use: OVSAYO (RRID:CVCL_3115)
Comments Problematic cell line: Misclassified. Originally thought to be an ovarian clear cell adenocarcinoma but shown to be a high grade ovarian serous adenocarcinoma (PubMed=24023729).
Population: Japanese.
Doubling time: 88 hours (PubMed=9328139; PubMed=11121861).
Omics: GPI-anchored proteins analysis by proteomics.
Omics: Transcriptome analysis by microarray.
Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
Sequence variations
Disease High grade ovarian serous adenocarcinoma (NCIt: C105555)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
Sex of cell Female
Age at sampling 64Y
Category Cancer cell line
STR profile Source(s): JCRB=JCRB1047


Run an STR similarity search on this cell line

PubMed=9328139; DOI=10.1038/bjc.1997.471
Yanagibashi T., Gorai I., Nakazawa T., Miyagi E., Hirahara F., Kitamura H., Minaguchi H.
Complexity of expression of the intermediate filaments of six new human ovarian carcinoma cell lines: new expression of cytokeratin 20.
Br. J. Cancer 76:829-835(1997)

PubMed=11121861; DOI=10.1016/S0304-3835(00)00605-4
Ohta I., Gorai I., Miyamoto Y., Yang J., Zheng J.-H., Kawata N., Hirahara F., Shirotake S.
Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells.
Cancer Lett. 162:39-48(2001)

PubMed=15677628; DOI=10.1093/carcin/bgi032
Gorringe K.L., Chin S.-F., Pharoah P.D.P., Staines J.M., Oliveira C., Edwards P.A.W., Caldas C.
Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.
Carcinogenesis 26:923-930(2005)

PubMed=20081105; DOI=10.1210/me.2009-0295
Nagaraja A.K., Creighton C.J., Yu Z.-F., Zhu H.-F., Gunaratne P.H., Reid J.G., Olokpa E., Itamochi H., Ueno N.T., Hawkins S.M., Anderson M.L., Matzuk M.M.
A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
Mol. Endocrinol. 24:447-463(2010)

PubMed=24023729; DOI=10.1371/journal.pone.0072162
Anglesio M.S., Wiegand K.C., Melnyk N., Chow C., Salamanca C.M., Prentice L.M., Senz J., Yang W., Spillman M.A., Cochrane D.R., Shumansky K., Shah S.P., Kalloger S.E., Huntsman D.G.
Type-specific cell line models for type-specific ovarian cancer research.
PLoS ONE 8:E72162-E72162(2013)

PubMed=26972028; DOI=10.1016/j.jprot.2016.03.008
Masuishi Y., Kimura Y., Arakawa N., Hirano H.
Identification of glycosylphosphatidylinositol-anchored proteins and omega-sites using TiO2-based affinity purification followed by hydrogen fluoride treatment.
J. Proteomics 139:77-83(2016)

PubMed=27141528; DOI=10.1016/j.dib.2016.04.001
Masuishi Y., Kimura Y., Arakawa N., Hirano H.
Data for identification of GPI-anchored peptides and omega-sites in cancer cell lines.
Data Brief 7:1302-1305(2016)

Cell line collections (Providers) JCRB; JCRB1047
JCRB; NIHS0300 - Discontinued
JCRB; NIHS0342 - Discontinued
Cell line databases/resources CLO; CLO_0037100
cancercelllines; CVCL_3115
Cell_Model_Passport; SIDM00464
Anatomy/cell type resources BTO; BTO:0003501
Encyclopedic resources Wikidata; Q54937037
Gene expression databases GEO; GSM416680
Proteomic databases PRIDE; PXD003105
Entry history
Entry creation04-Apr-2012
Last entry update02-May-2024
Version number20